Valve with internal lifter

Information

  • Patent Grant
  • 7887519
  • Patent Number
    7,887,519
  • Date Filed
    Tuesday, January 10, 2006
    18 years ago
  • Date Issued
    Tuesday, February 15, 2011
    13 years ago
Abstract
A medical valve having a close mode and an open mode includes a housing having a proximal end, a distal end, and an interior. The valve also has a valve mechanism within the interior. In illustrative embodiments, the valve mechanism has a gland member and a lifter member. The lifter member moves the gland member toward the proximal end of the housing as the valve transitions from the closed mode to the open mode.
Description
RELATED APPLICATIONS

This application is related to the following U.S. patents and U.S. patent applications, the disclosures of which are incorporated herein, in their entireties, by reference:

    • U.S. Pat. No. 6,039,302;
    • U.S. Pat. No. 6,883,778;
    • U.S. Pat. No. 6,755,391;
    • U.S. application Ser. No. 10/224,299;
    • U.S. Pat. No. 6,869,426;
    • U.S. application Ser. No. 10/687,515; and
    • U.S. application Ser. No. 10/700,344.


FIELD OF THE INVENTION

The invention generally relates to medical products and, more particularly, the invention relates to substantially eliminating undesired fluid drawback through a medical valve.


BACKGROUND OF THE INVENTION

In general terms, medical valving devices often act as a sealed port that may be repeatedly accessed to non-invasively inject fluid into (or withdraw fluid from) a patient's vasculature. Consequently, a medical valve acting as a fluid port permits the patient's vasculature to be freely accessed without requiring such patient's skin be repeatedly pierced by a needle.


More specifically, after it is inserted into a medical valve, a syringe may freely inject or withdraw fluid from the patient. Problems arise, however, when the syringe is withdrawn from the valve. Specifically, a back pressure (i.e., a proximally directed pressure) produced by the withdrawing syringe undesirably can draw blood proximally into the valve or a catheter connected to the valve. In addition to coagulating and impeding the mechanical operation of the valve, blood in the valve also compromises the sterility of the valve and/or catheter.


SUMMARY OF THE INVENTION

In accordance with one aspect of the invention, a medical valve having a closed mode and an open mode includes a housing having a proximal end, a distal end, and an interior. The valve also has a valve mechanism within the interior. In illustrative embodiments, the valve mechanism has a gland member and a lifter member. The lifter member moves the gland member toward the proximal end of the housing as the valve transitions from the closed mode to the open mode.





BRIEF DESCRIPTION OF THE DRAWINGS

The foregoing and advantages of the invention will be appreciated more fully from the following further description thereof with reference to the accompanying drawings wherein:



FIG. 1 schematically shows an isometric view of a medical valve that may be configured in accordance with illustrative embodiments of the invention.



FIG. 2A schematically shows a cross-sectional view of the medical valve of FIG. 1 in accordance with a first embodiment of the invention.



FIG. 2B schematically shows a cross-sectional view of the medical valve of FIG. 1 in accordance with a second embodiment of the invention.



FIG. 2C schematically shows a cross-sectional view of the medical valve of FIG. 1 in accordance with a third embodiment of the invention.



FIG. 2D schematically shows a cross-sectional view of the medical valve of FIG. 1 in accordance with a fourth embodiment of the invention.



FIG. 2E schematically shows a cross-sectional view of the medical valve of FIG. 1 in the open mode in accordance with embodiments of the invention.



FIG. 3A schematically shows a wireframe in view of the embodiment shown in FIG. 2A.



FIG. 3B schematically shows a wireframe in view of the embodiment shown in FIG. 2B.



FIG. 3C schematically shows a wireframe in view of the embodiment shown in FIG. 2C.



FIG. 3D schematically shows a wireframe in view of the embodiment shown in FIG. 2D.





DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS

In illustrative embodiments of the invention, a valve produces a positive, distally directed pressure (i.e., toward its outlet) when a nozzle or syringe is withdrawn. Such pressure should prevent non-negligible amounts of fluid from being drawn into the valve at such time. To these ends, the valve has an interior fluid chamber/flow channel sized and configured 1) to expand its volume as the valve transitions toward the open mode, and 2) to reduce its volume as the valve transitions toward the closed mode. Details of this and related embodiments also are discussed below.



FIG. 1 schematically shows a medical valve 10 that is configured to reduce fluid drawback (a.k.a. “back-flow,” noted above) when a syringe or other type of nozzle is withdrawn from it. The valve 10 has a valve body/housing 12 with proximal and distal ports 14 and 16 (also respectively referred to herein as “inlet 14” and “outlet 16”). The valve body has an internal chamber 18 containing a valve element (shown in FIGS. 2A, 2B, 2C, 2D, 3A, 3B, 3C, and 3D) that controls fluid flow through the valve 10. The fluid preferably is in liquid form, such as saline or a liquid medication, to pass through a centrally formed fluid channel that extends between the inlet 14 and the outlet 16. Although much of the discussion herein refers to the proximal port 14 as a fluid inlet, and the distal port 16 as a fluid outlet, the proximal and distal ports 14 and 16 also may be respectively used as outlet and inlet ports.



FIGS. 2A and 3A schematically shows cross-sectional views of the valve 10 of FIG. 1 in accordance with a first embodiment of the invention. The housing 12 includes inlet and outlet housing portions 20 and 22, which illustratively are formed from a hard plastic material that are snap-fit together. For example, the housing portions 20 and 22 may be configured to snap fit together in accordance with the teachings of co-pending, commonly owned U.S. patent application Ser. No. 10/265,292, filed Oct. 4, 2002, the disclosure of which is incorporated herein, in its entirety, by reference. It should be noted that although some embodiments are discussed as being snap-fit components, various embodiments of the invention may be coupled by either snap-fit or other means, such as by ultrasonic welding. Accordingly, such embodiments are not intended to be limited to snap-fit components.


When coupled, the housing portions 20 and 22 form the internal chamber 18, which is shaped to comply with the operation of its internal valve element (discussed below). The proximal port 14, which is part of this chamber 18, illustratively is contoured to accept various types of nozzles, such as those complying with ANSI/ISO standards (e.g., luers complying with ANSI and/or ISO standards).


The valve element has a stretchable, resilient, and compressible member (referred to in various embodiments herein as “gland 24”) secured between the inlet housing 20 and outlet housing 22. In illustrative embodiments, the gland 24 is formed from an elastomeric material, such as silicone or rubber. Other materials having similar properties may be used, however, so long as they can perform the functions discussed herein.


The gland 24 has several cooperating sections for controlling fluid flow through the valve 10 while substantially eliminating fluid drawback. Namely, the gland 24 has a proximal section 26 near its proximal end, a distal section 28 near its distal end, and a central section 30 between the proximal and distal sections 26 and 28. The three sections 26, 28, and 30 together form a portion of a contiguous fluid flow path that extends the length of the valve 10. In addition, the gland 24 also has an attachment section 32 for securing the gland 24 within the valve 10 and maintaining fluid flow in the flow channel. In illustrative embodiments, the proximal section 26 of the gland 24 has a slit 33 for providing a low pressure seal.


The valve element also includes a rigid and longitudinally movable cannula 34 secured within the gland 24, and a lifter 36 for urging the gland 24 proximally as the valve 10 transitions from a closed mode to an open mode.


In illustrative embodiments, the cannula 34 is a hollow needle that, together with the gland 24, form a part of the internal flow channel within the valve 10. The cannula 34 is open at its proximal end, closed at its distal end, and has holes 38 in its side just proximal to its distal end. The cannula 34 also has a protruding distal end that facilitates assembly. As shown in the Figures, when in the closed position, the holes 38 are occluded by the gland 24. An annular corner 35 of the interior chamber 18 aids in the sealing the holes 38. In addition, the slit 33 also is normally closed when the valve 10 is in the closed mode.



FIG. 2A also shows an isometric view of the lifter 36. The lifter 36 has a main body 40 supported by the base of the interior chamber 18, and a top portion 42 abutting the bottom of the gland 24. The main body 40 illustratively forms a plurality of living hinges 44 that flex as the valve 10 transitions between opened and closed modes. The lifter 36 illustratively is formed from a flexible, hard plastic.


When the valve 10 is in the fully closed position, the proximal section 26 of the gland 24 is flush with, or extends slightly above, the exterior inlet face of the housing 12 (see, for example, FIGS. 3A and 3B). The proximal section 26 and the exterior inlet face thus present a swabbable surface. In other words, the proximal section 26 and the exterior inlet face may be easily wiped clean by any conventional means, such as with an alcohol swab. As mentioned in the above noted incorporated patent, valves having swabbable surfaces are known in the art as “swabbable valves.” In other embodiments, however, the valve 10 is not a swabbable valve.


Insertion of a nozzle (e.g., a luer 52) into the proximal port 14 forces the gland 24 to move (radially and longitudinally, as discussed below) to an open position. When in that position, a flow channel from the proximal port to the distal port 16 is considered to be formed as follows:

    • First through the proximal port 14 and the slit 33 in the proximal section 26,
    • Then through the interior of the gland 24 to the open end of the cannula 34,
    • Through the cannula channel to the cannula holes 38, into internal chamber 18 and through chamber channel 50,
    • Through a distal hole in the housing 12 to an outlet channel terminating at the distal port 16.


To open this fluid channel, the proximal section 26 of the gland 24 collapses onto the top surface of the cannula 34 to open the slit 33. The cannula 34 also begins traversing distally, thus prying the main body 40 of the lifter 36 radially outwardly. Consequently, the main body 40 of the lifter 36 flexes about the three living hinges 44. This causes the top portion 42 of the lifter 36 to move proximally. Due to their spatial relationship, this lifter movement thus urges the bottom portion of the gland 24 proximally. Accordingly, the overall fluid volume within the flow channel increases.


Removal of the nozzle has a corresponding effect of decreasing the overall flow channel volume. Specifically, as the valve element returns toward the closed position, the gland 24 returns to its relaxed state, which reduces overall internal chamber 18 of volume. As noted above, this volume change should produce a positively directed pressure toward the distal port 16. Such positive pressure consequently should substantially eliminate fluid drawback into the valve 10 or its attached catheter.


It should be noted, however, that the actual volume of the flow channel is anticipated to vary as the valve element moves proximally. In fact, during the return cycle, there could be times when fluid is drawn toward or back into the valve 10 and/or catheter. In illustrative embodiments, however, the overall volume change has a net effect of producing a net positive pressure through the outlet 16, thus substantially eliminating fluid drawback.



FIGS. 2B, 2C, 2D and their corresponding wireframe representations show alternate embodiments of the invention. For example, FIGS. 2B and 3B have a different hinge structure than that shown in FIGS. 2A and 3A. Specifically, unlike the hinges 44 shown in FIG. 2A, each of the hinges 44 shown in FIG. 2B has a specialized contour and varying thickness.


In a manner similar to in FIG. 2B, the hinges 44 in FIG. 2C also are specially contoured. In addition, the lifter 36 also has a radial base 40A to provide better support within the interior chamber 18.



FIGS. 2D and 3D schematically show yet another embodiment of the lifter 36. In a manner similar to other embodiments, this embodiment also has specially contoured hinges 44. Unlike other embodiments, however, both the main body 40 and the top portion 42 taper radially inwardly as they approach the hinges 44. It is anticipated that this tapered design will proximally displace the gland 24 in a more efficient and controllable manner.


Although the above discussion discloses various exemplary embodiments of the invention, it should be apparent that those skilled in the art can make various modifications that will achieve some of the advantages of the invention without departing from the true scope of the invention.

Claims
  • 1. A medical valve having a closed mode and an open mode, the valve comprising: a housing having a proximal end, a distal end, and an interior;a valve mechanism within the interior,the valve mechanism including a gland member and a movable lifter member, the lifter member moving at least a portion of the gland member toward the proximal end of the housing as the valve transitions from the closed mode toward the open mode, the closed mode preventing fluid flow through the valve, the open mode permitting fluid flow through the valve.
  • 2. The medical valve as defined by claim 1 wherein the housing forms a fluid channel having an internal chamber, the internal chamber being at least a portion of the fluid channel, proximal movement of the gland member by the lifter member causing the internal chamber to have an increasing volume.
  • 3. The medical valve as defined by claim 1 wherein the housing forms a fluid channel within the interior, the fluid channel having an internal chamber having a decreasing size as the valve transitions from the open mode toward the closed mode.
  • 4. The medical valve as defined by claim 3 wherein the housing has an outlet port, the decreasing size of the internal chamber producing a distally directed pressure through the outlet port.
  • 5. The medical valve as defined by claim 4 wherein the volume of the fluid channel decreases as the internal chamber size decreases, the decreasing fluid channel volume and decreasing internal chamber volume producing the distally directed pressure through the outlet port.
  • 6. The medical valve as defined by claim 1 wherein the lifter member has an arm with a living hinge, the arm being in contact with the gland member.
  • 7. The medical valve as defined by claim 1 wherein the valve mechanism includes a cannula coupled to the gland member, the cannula and gland member forming two spaced apart seals.
  • 8. The medical valve as defined by claim 1 wherein the gland member forms a swabbable surface with the housing.
  • 9. The medical valve as defined by claim 1 wherein the housing forms a fluid channel within the interior, the fluid channel having an internal chamber having a decreasing size as the valve transitions from the open mode toward the closed mode.
  • 10. The medical valve as defined by claim 9 wherein the housing has an outlet port, the decreasing size of the internal chamber producing a positive pressure through the outlet port.
  • 11. The medical valve as defined by claim 10 wherein the volume of the fluid channel decreases as the internal chamber volume decreases, the decreasing fluid channel volume and decreasing internal chamber volume producing the positive pressure through the outlet port.
  • 12. The medical valve as defined by claim 10 wherein the gland and lifting means includes means for producing a distally directed pressure through the distal end as the valve moves from the open mode toward the closed mode.
  • 13. The medical valve as defined by claim 1 wherein the valve prevents fluid flow through the valve when in the closed mode.
  • 14. The medical valve as defined by claim 1 wherein the valve transitions from the closed mode to the open mode after insertion of a medical implement into an inlet of the medical valve.
  • 15. A medical valve having a closed mode and an open mode, the valve comprising: a housing having a proximal end, a distal end, and an interior;means for valving fluid through the interior,the valving means including a gland member and lifting means, the lifting means moving at least a portion of the gland member toward the proximal end of the housing as the valve transitions from the closed mode to the open mode, the closed mode preventing fluid flow through the valve, the open mode permitting fluid flow through the valve.
PRIORITY

This patent application claims priority from provisional U.S. patent application No. 60/644,068, filed Jan. 14, 2005, entitled, “VALVE WITH INTERNAL LIFTER,” and naming Andrew L. Cote and Brian L Newton as inventors, the disclosure of which is incorporated herein, in its entirety, by reference.

US Referenced Citations (190)
Number Name Date Kind
2594405 Deters Apr 1952 A
2693801 Foreman Nov 1954 A
2705501 Frizsch et al. Apr 1955 A
2756740 Deane Jul 1956 A
2899975 Fernandez Aug 1959 A
2999499 Willett Sep 1961 A
3087492 Garth Apr 1963 A
3105511 Murphy, Jr. Oct 1963 A
3192949 De See Jul 1965 A
3385301 Harautuneian May 1968 A
3399677 Gould et al. Sep 1968 A
3416567 Von Dardel et al. Dec 1968 A
3506005 Gilio et al. Apr 1970 A
3538950 Porteners Nov 1970 A
3570484 Steer Mar 1971 A
3572375 Rosenberg Mar 1971 A
3726282 Patel Apr 1973 A
3806086 Cloyd Apr 1974 A
3831629 Mackal et al. Aug 1974 A
3838843 Bernhard Oct 1974 A
3923065 Nozick et al. Dec 1975 A
3965910 Fischer Jun 1976 A
3994293 Ferro Nov 1976 A
4063555 Ulinder Dec 1977 A
4080965 Phillips Mar 1978 A
4094195 Friswell et al. Jun 1978 A
4094196 Friswell Jun 1978 A
4116201 Shah Sep 1978 A
4121585 Becker, Jr. Oct 1978 A
4143853 Abramson Mar 1979 A
4223808 Williams et al. Sep 1980 A
4300571 Waldbillig Nov 1981 A
4324239 Gordon et al. Apr 1982 A
4333455 Bodicky Jun 1982 A
4334551 Pfister Jun 1982 A
4344435 Aubin Aug 1982 A
4387879 Tauschinski Jun 1983 A
4401432 Schwartz Aug 1983 A
4421296 Stephens Dec 1983 A
4496348 Genese et al. Jan 1985 A
4498658 Mikiya Feb 1985 A
4534758 Akers et al. Aug 1985 A
4535820 Raines Aug 1985 A
4550785 Hibbard et al. Nov 1985 A
4551136 Mandl Nov 1985 A
4585435 Vaillancourt Apr 1986 A
4596557 Pexa Jun 1986 A
4611973 Birdwell Sep 1986 A
4617015 Foltz Oct 1986 A
4661110 Fortier et al. Apr 1987 A
4675003 Hooven Jun 1987 A
4681132 Lardner Jul 1987 A
4683905 Vigneau et al. Aug 1987 A
4683916 Raines Aug 1987 A
4698061 Makaryk et al. Oct 1987 A
4710168 Schwab et al. Dec 1987 A
4712583 Pelmulder et al. Dec 1987 A
4743235 Waldbillig et al. May 1988 A
4745950 Mathieu May 1988 A
4749003 Leason Jun 1988 A
4752287 Kurtz et al. Jun 1988 A
4752292 Lopez et al. Jun 1988 A
4758224 Siposs Jul 1988 A
4776369 Lardner et al. Oct 1988 A
4809679 Shimonaka et al. Mar 1989 A
4816020 Brownell Mar 1989 A
4819684 Zaugg et al. Apr 1989 A
4850978 Dudar et al. Jul 1989 A
4874377 Newgard et al. Oct 1989 A
4915687 Sivert Apr 1990 A
4917668 Haindl Apr 1990 A
4935010 Cox et al. Jun 1990 A
4966199 Ruschke Oct 1990 A
5006114 Rogers et al. Apr 1991 A
5041087 Loo et al. Aug 1991 A
5048537 Messinger Sep 1991 A
5049128 Duquette Sep 1991 A
5059175 Hanover et al. Oct 1991 A
5065783 Ogle, II Nov 1991 A
5080654 Picha et al. Jan 1992 A
5085645 Purdy et al. Feb 1992 A
5100394 Dudar et al. Mar 1992 A
5108380 Herlitze et al. Apr 1992 A
5122123 Vaillancourt Jun 1992 A
5127904 Loo et al. Jul 1992 A
5147333 Raines Sep 1992 A
5171230 Eland et al. Dec 1992 A
5184652 Fan Feb 1993 A
5199947 Lopez et al. Apr 1993 A
5201715 Masters Apr 1993 A
5203775 Frank et al. Apr 1993 A
5215538 Larkin Jun 1993 A
5221271 Nicholson et al. Jun 1993 A
5230706 Duquette Jul 1993 A
5242393 Brimhall et al. Sep 1993 A
5242432 DeFrank Sep 1993 A
5269771 Thomas et al. Dec 1993 A
5280876 Atkins Jan 1994 A
5300034 Behnke et al. Apr 1994 A
5320328 Decloux et al. Jun 1994 A
5330435 Vaillancourt Jul 1994 A
5349984 Weinheimer et al. Sep 1994 A
5360413 Leason et al. Nov 1994 A
5380306 Brinon Jan 1995 A
5390898 Smedley et al. Feb 1995 A
5401255 Sutherland et al. Mar 1995 A
5439451 Collinson et al. Aug 1995 A
5441487 Vedder Aug 1995 A
5465938 Werge et al. Nov 1995 A
5474536 Bonaldo Dec 1995 A
5474544 Lynn Dec 1995 A
5509433 Paradis Apr 1996 A
5509912 Vaillancourt et al. Apr 1996 A
5520665 Fleetwood May 1996 A
5520666 Choudhury et al. May 1996 A
5533708 Atkinson et al. Jul 1996 A
5533983 Haining Jul 1996 A
5540661 Tomisaka et al. Jul 1996 A
5549566 Elias et al. Aug 1996 A
5569209 Roitman Oct 1996 A
5569235 Ross et al. Oct 1996 A
5573516 Tyner Nov 1996 A
5578059 Patzer Nov 1996 A
5613663 Schmidt et al. Mar 1997 A
5616129 Mayer Apr 1997 A
5616130 Mayer Apr 1997 A
5620434 Brony Apr 1997 A
5674206 Allton et al. Oct 1997 A
5676346 Leinsing Oct 1997 A
5685842 Drivas Nov 1997 A
5685866 Lopez Nov 1997 A
5694686 Lopez Dec 1997 A
5695466 Lopez et al. Dec 1997 A
5699821 Paradis Dec 1997 A
5700248 Lopez Dec 1997 A
5730418 Feith et al. Mar 1998 A
5749861 Guala et al. May 1998 A
RE35841 Frank et al. Jul 1998 E
5788215 Ryan Aug 1998 A
5806831 Paradis Sep 1998 A
5817069 Arnett Oct 1998 A
5820601 Mayer Oct 1998 A
5921264 Paradis Jul 1999 A
5954313 Ryan Sep 1999 A
6029946 Doyle Feb 2000 A
6036171 Weinheimer et al. Mar 2000 A
6039302 Cote, Sr. et al. Mar 2000 A
6048335 Mayer Apr 2000 A
6050978 Orr et al. Apr 2000 A
6063062 Paradis May 2000 A
6068011 Paradis May 2000 A
6079432 Paradis Jun 2000 A
6089541 Weinheimer et al. Jul 2000 A
6152900 Mayer Nov 2000 A
6158458 Ryan Dec 2000 A
6189859 Rohrbough et al. Feb 2001 B1
6206860 Richmond Mar 2001 B1
6228069 Barth et al. May 2001 B1
6245048 Fangrow, Jr. et al. Jun 2001 B1
6290206 Doyle Sep 2001 B1
6344033 Jepson et al. Feb 2002 B1
6428520 Lopez et al. Aug 2002 B1
6485472 Richmond Nov 2002 B1
6543745 Enerson Apr 2003 B1
6581906 Pott et al. Jun 2003 B2
6585229 Cote, Sr. et al. Jul 2003 B2
6595964 Finley et al. Jul 2003 B2
6595981 Huet Jul 2003 B2
6609696 Enerson Aug 2003 B2
6626418 Kiehne Sep 2003 B2
6669673 Lopez Dec 2003 B2
6755391 Newton et al. Jun 2004 B2
6869426 Ganem Mar 2005 B2
6883778 Newton et al. Apr 2005 B1
6892998 Newton May 2005 B2
7014169 Newton et al. Mar 2006 B2
7037302 Vaillancourt May 2006 B2
7100890 Cote, Sr. et al. Sep 2006 B2
7396348 Newton et al. Jul 2008 B2
20020024036 Rohrbough et al. Feb 2002 A1
20030050610 Newton et al. Mar 2003 A1
20030060779 Richmond Mar 2003 A1
20030093061 Ganem May 2003 A1
20030098430 Leinsing et al. May 2003 A1
20030141477 Miller Jul 2003 A1
20040073171 Rogers et al. Apr 2004 A1
20040138626 Cote, Sr. et al. Jul 2004 A1
20050165365 Newton et al. Jul 2005 A1
20060142735 Whitley Jun 2006 A1
20080275405 Newton et al. Nov 2008 A1
Foreign Referenced Citations (14)
Number Date Country
0268480 May 1998 EP
1243285 Sep 2002 EP
2079162 Jan 1982 GB
WO 8302559 Aug 1983 WO
WO 9311828 Jun 1993 WO
WO 9600107 Jan 1996 WO
WO 9739791 Oct 1997 WO
WO 9822178 May 1998 WO
WO 9826835 Jun 1998 WO
WO 9839594 Sep 1998 WO
WO 0044433 Aug 2000 WO
WO 03018104 Mar 2003 WO
WO 03018105 Mar 2003 WO
WO 2004060466 Jul 2004 WO
Related Publications (1)
Number Date Country
20060264841 A1 Nov 2006 US
Provisional Applications (1)
Number Date Country
60644068 Jan 2005 US